End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Sales 2021 | 1.3M 950K 74.74M | Sales 2022 | 939K 688K 54.16M | Capitalization | 10.42M 7.64M 601M |
---|---|---|---|---|---|
Net income 2021 | -6M -4.4M -346M | Net income 2022 | -6M -4.4M -346M | EV / Sales 2021 | 21.5 x |
Net Debt 2021 | 5.4M 3.96M 311M | Net Debt 2022 | 5.8M 4.25M 334M | EV / Sales 2022 | 17.3 x |
P/E ratio 2021 |
-3.24
x | P/E ratio 2022 |
-1.47
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.89% |
Managers | Title | Age | Since |
---|---|---|---|
Graham W. Burton
FOU | Founder | - | 03/08/05 |
G. Anthony
CEO | Chief Executive Officer | 68 | 03/04/14 |
Ira Levy
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Kraws
CHM | Chairman | 59 | 30/11/13 |
Aubrey Dan
BRD | Director/Board Member | - | 21/11/17 |
G. Anthony
CEO | Chief Executive Officer | 68 | 03/04/14 |
1st Jan change | Capi. | |
---|---|---|
+18.35% | 12.15B | |
+13.73% | 6.57B | |
+2.99% | 5.36B | |
+14.80% | 5.09B | |
-17.79% | 2.79B | |
+4.52% | 1.95B | |
-5.87% | 1.37B | |
-7.83% | 975M | |
-14.94% | 966M |